The China 3D cardiac mapping market has showcased significant growth, with its valuation increasing from $55.55 million in 2019 to a projected $150.59 million by 2027. This report offers a detailed ...

The global cardiac mapping market stood at US$ 3 billion in 2023, and the global market is projected to reach US$ 5.5 billion ...

Stereotaxis (NYSE:STXS) announced today that its Magbot magnetic navigation ablation catheter received regulatory approval in ...

(688351.SH, "MicroPort EP”), today announced that the Magbot™ Magnetic Navigation Ablation Catheter has received regulatory ...

TCAI is the first to use Medtronic’s Affera mapping and ablation system with a Sphere-9 catheter since it received FDA ...

"This all-in-one, first-of-its-kind catheter allows physicians to map, ablate and ... for the treatment of heart arrhythmias continues to advance, the Texas Cardiac Arrhythmia Institute is ...

A hospital in Texas announced that its electrophysiologists completed the first U.S. cases with the Medtronic (NYSE:MDT) ...

"As global innovation for the treatment of heart arrhythmias ... in-us-to-use-fda-approved-mapping-and-dual-energy-ablation-catheter-302321221.html SOURCE Texas Cardiac Arrhythmia Institute ...

Medtronic and Boston Scientific, which both have major cardiac-device operations in Minnesota ... devices physicians can ...